Sun Pharma Advanced Research Company
SPARC · Pharma > Pharmaceuticals & Drugs Listing date: July 18, 2007 · Employees: 410 · Mumbai · http://www.sparc.life

Stock Price vs Company Growth
1d
1.6%
1w
3.5%
1m
20.9%
3m
16.2%
6m
30.5%
1y
62.0%
5y
1.4%
10y
11.2%
all
3.2%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowDec10Jun14Dec17Jun21Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

148 1.6%
109
183
Company Overview

Sales
61.1 Cr
Growth: -27.3%
Profit after Tax
-389 Cr
Growth: -4.9%
Small Cap
4,803 Cr
P/S: 78.6x
Industry P/S: 2.7x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 61.1
Growth -27.3%
EBITDA -614.6%
P/S 78.6x
Dividend 0.0%
P/E -12.4x
Book Value ₹ -4.84
PEG Ratio 0.4x
ROE 999.0%
P/B N/A
Shareholding Pattern

Institutions
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun21Mar22Sep22Dec22Mar23Dec24
Promoters
Shanghvi Finance Private Limited
52.36 %
Dilip Shantilal Shanghvi
10.72 %
Aditya Medisales Limited
1.87 %
Raksha S.Valia
1.58 %
Sudhir Valia
0.7 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun21Mar22Sep22Dec22Mar23Dec24
Others
Sun Pharmaceutical Industries Key Employees Benefit Trust
3.94 %
Lakshdeep Investments & Finance (P) Ltd.
1.94 %
Created with Highcharts 8.2.2Dec19Mar20Jun20Sep20Dec20Mar21Jun21Mar22Sep22Dec22Mar23Dec24
Increase    Decrease    No change
Company Profile Detailed

The company is engaged in the pharmaceutical research and development. The company’s core focus is innovation and new product development for global markets. SPARC undertakes projects in research and technology for new chemical entities (NCE’s) or new molecules, and novel drug delivery systems (NDDS).
Investors (66)
Followers (5)